Affliation: Semmelweis University, HU
Keywords: molecular oncohematology, cancer evolution, treatment response monitoring, next-generation sequencing, automated microscopy
Donát Alpár studied biology & chemistry and received his PhD in molecular pathology from the University of Pécs, Hungary. After serving as the head of a cancer cytogenetic laboratory for nearly five years, he spent altogether eight years at the Institute of Cancer Research (London) and at the Center for Molecular Medicine of the Austrian Academy of Sciences (Vienna). His research at the Semmelweis University focuses on the genome, epigenome and transcriptome based evolutionary scrutiny of hematological malignancies, and on the development of automated microscopy and next-generation sequencing based applications with an ultimate goal to improve cancer diagnostics and refine personalized treatment strategies.
He published 50+ scientific papers/book chapters and completed 100+ reviews, mainly for hematology and pathology focused journals. His scientific activity was supported and recognized nationally and internationally with various scholarships (Fulbright, Marie Curie, János Bolyai, ISAC Marylou Ingram Program, Hungarian National Excellence Program), basic research and R&D grants, as well as awards from the University of Pécs, the Hungarian Cancer Society and the International Society of Paediatric Oncology. He is a former Novartis International Biotechnology Leadership Camp attendee, Falling Walls Lab finalist, Lindau Nobel Laureate Meeting participant and STEM ambassador in the Greater London Area. His students received 10+ prizes at various national and international scientific competitions, and two of them earned their PhD with excellent grade in 2020. He is also a founding member of the Hungarian Young Academy and served as its board member between 2019 and 2021.